• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CORPORATE COLLECTIVE CONCENTRATE- NATURALYTE; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CORPORATE COLLECTIVE CONCENTRATE- NATURALYTE; DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER) Back to Search Results
Catalog Number UNKNOWN-CONCENTRATE-NATURALYTE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Myocardial Infarction (1969)
Event Date 01/01/2018
Event Type  Injury  
Manufacturer Narrative
Clinical investigation: it is unknown if a temporal relationship exists between hd therapy utilizing collective concentrate ¿ naturalyte, collective concentrate ¿ granuflo and the patient reported serious adverse events of multiple myocardial infarctions.The etiology of the events is unknown; therefore, causality cannot be established.The incidence of acute coronary event(s), specifically myocardial infarctions in the end-stage renal disease (esrd) population are considerably higher than the general population.Based on the information available, the collective concentrates naturalyte and granuflo cannot be disassociated from the events.While there is no objective evidence indicating a fresenius product(s) or device(s) deficiency or malfunction caused or contributed to the events.The lack of detailed information, treatment records, samples for evaluation and discharge summaries prevents the collective concentrates from being excluded as having a possible causal or contributory role in the events.Plant investigation: a review of the file was performed and it was determined that there were no lot numbers, product codes, clinic or patient identifiers, or a specific timeframe recorded.Due to the lack of information present, a full investigation cannot be performed.
 
Event Description
A (b)(6) social media user reported experiencing experienced three heart attacks (myocardial infarctions) in the last ten years (two from atrial fibrillation, and one from ventricular fibrillation).Due to the lack of additional information, verbal and/or written correspondence was not possible.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COLLECTIVE CONCENTRATE- NATURALYTE
Type of Device
DIALYSATE CONCENTRATE FOR HEMODIALYSIS (LIQUID OR POWDER)
Manufacturer (Section D)
CORPORATE
920 winter street
waltham MA 02451
Manufacturer (Section G)
CORPORATE
920 winter street
waltham MA 02451
Manufacturer Contact
matthew amaral
920 winter st
waltham, MA 02451
7816999758
MDR Report Key10023939
MDR Text Key189840321
Report Number1225714-2020-00019
Device Sequence Number1
Product Code KPO
Combination Product (y/n)N
PMA/PMN Number
K981043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Type of Report Initial,Followup
Report Date 05/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/05/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Catalogue NumberUNKNOWN-CONCENTRATE-NATURALYTE
Was Device Available for Evaluation? No
Device AgeMO
Date Manufacturer Received05/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
-
-